High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis

被引：51
|
作者：
Lemesle, G. [1 ,2 ,3 ]
Schurtz, G. [1 ]
Bauters, C. [1 ,2 ,3 ]
Hamon, M. [4 ,5 ]
机构：
[1] CHRU Lille, F-59037 Lille, France
[2] Inst Pasteur, Inserm U744, F-59019 Lille, France
[3] Univ Lille, Fac Med, Lille, France
[4] Ctr Hosp Univ Caen, Caen, France
[5] Fac Med Caen, Caen, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷 / 06期
关键词：
acute coronary syndrome; antiplatelet agents; coronary artery disease; percutaneous coronary intervention; platelet function tests; ACUTE CORONARY SYNDROME; ASPIRIN-TREATED PATIENTS; MYOCARDIAL-INFARCTION; RANDOMIZED ASSESSMENT; DOSE CLOPIDOGREL; ACHIEVES GREATER; INHIBITION; INTERVENTION; EVENTS; IMPACT;
D O I：
10.1111/jth.12907
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BackgroundTicagrelor and prasugrel have shown superiority over clopidogrel. However, it remains unclear if one is superior to another regarding on-treatment platelet reactivity. ObjectivesTo compare the impact of ticagrelor and prasugrel on high on-treatment platelet reactivity (HTPR). MethodsThe PubMed and Cochrane databases were searched for eligible studies in December 2014. Studies were eligible if they compared ticagrelor and prasugrel regarding high on-treatment platelet reactivity (HTPR). Pooled estimates were calculated by using a random-effects model with 95% confidence intervals. ResultsWe included 14 studies and 1822 patients: 805 and 1017 in the ticagrelor and prasugrel groups, respectively. The rate of HTPR was significantly lower in the ticagrelor group: 1.5% vs. 9.8% (RR=0.27 [0.14-0.50]). The pre-specified analysis focusing on randomized trials (n=10) showed consistent results (RR=0.27 [0.12-0.60]). ConclusionOur results suggest that ticagrelor allows a higher platelet reactivity inhibition as compared with prasugrel and leads to a further decrease in the rate of HTPR.
引用
收藏
页码：931 / 942
页数：12
相关论文
共 50 条
  • [41] Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on-treatment platelet reactivity
    Alexopoulos, D.
    Panagiotou, A.
    Xanthopoulou, I.
    Komninakis, D.
    Kassimis, G.
    Davlouros, P.
    Fourtounas, C.
    Goumenos, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) : 2379 - 2385
  • [42] Ticagrelor Versus Clopidogrel in Endovascular Therapy for Cerebral Aneurysms: A Systematic Review and Meta-Analysis
    Al-Salihi, Mohammed Maan
    Saha, Ram
    Gillani, Syed A.
    Al-Jebur, Maryam Sabah
    Al-Salihi, Yezan
    Roy, Anil
    Dalal, Shamser Singh
    Saleh, Ahmed
    Siddiq, Farhan
    Ayyad, Ali
    Qureshi, Adnan I.
    WORLD NEUROSURGERY, 2024, 184
  • [43] Comparing Patient Profiles of Clopidogrel versus Ticagrelor: A Systematic Literature Review and Meta-Analysis
    Cuisset, Thomas
    Aponte, Zuleika
    Paek, Dara
    del Aguila, Michael
    Girotra, Shalini
    Sibbing, Dirk
    CIRCULATION, 2018, 138
  • [44] A Systematic Review and Meta-Analysis on the Impact of High On-Treatment Platelet Reactivity on Clinical Outcomes for Patients Taking ADP Receptor Inhibitors Following Lower Limb Arterial Endovascular Intervention
    Zlatanovic, Petar
    Wong, Kitty H. F.
    Kakkos, Stavros K.
    Twine, Christopher P.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2022, 63 (01) : 91 - 101
  • [45] High on-treatment platelet reactivity - definition and measurement
    Cattaneo, Marco
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) : 792 - 798
  • [46] HIGH ON-TREATMENT PLATELET REACTIVITY: NOT AN ISOLATED PROBLEM
    Jakl, M.
    Maly, J.
    Fatorova, I.
    Horacek, J.
    Pudil, R.
    HAEMATOLOGICA, 2013, 98 : 208 - 208
  • [47] Advances in Understanding "High on-Treatment Platelet Reactivity"
    Hayward, Catherine P. M.
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) : 799 - 800
  • [48] The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis
    Liu, Zhiyan
    Xiang, Qian
    Mu, Guangyan
    Xie, Qiufen
    Zhou, Shuang
    Wang, Zining
    Chen, Shuqing
    Hu, Kun
    Gong, Yanjun
    Jiang, Jie
    Cui, Yimin
    PLATELETS, 2020, 31 (01) : 3 - 14
  • [49] Prasugrel vs Ticagrelor for DAPT in Patients with ACS Undergoing PCI: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Al-Abdouh, Ahmad
    Barbarawi, Mahmoud
    Abusnina, Waiel
    Amr, Mahmoud
    Zhao, Di
    Savji, Nazir
    Hasan, Rani K.
    Michos, Erin D.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (12) : 1613 - 1618
  • [50] Differential effect of ticagrelor versus clopidogrel on the prevalence of high on-treatment platelet reactivity: results from the ONSET-OFFSET and RESPOND trials
    Bliden, K. P.
    Tantry, U. S.
    Antonino, M.
    Mahla, E.
    Gesheff, T.
    Tzevelekos, P.
    Butler, K.
    Wei, C.
    Gurbel, P. A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 173 - 173
12345